Brean Murray Cuts Lexmark (LXK) to Hold; Stepping to Neutral as Headwinds Flush Through
Get Alerts LXK Hot Sheet
Price: $40.49 --0%
Rating Summary:
0 Buy, 9 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
0 Buy, 9 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Brean Murray Carret & Co. downgraded Lexmark International (NYSE: LXK) from Buy to Hold.
Brean analyst says, "We'd look to again become constructive on shares as the headwinds abate. While we've held a more favorable view of LXK's 'normalized' earnings potential that the street (and believe likely wil again once the dust settles), we also believe it's likely that 1) Street EPS comes down within the ballpark of our new estimates and 2) until both revenue and margins sustainably stabilize, LXK will likely garner just 7-8x multiple, likely capping upside until these forces work through."
For more ratings news on Lexmark International click here and for the rating history of Lexmark International click here.
Shares of Lexmark International closed at $32.76 yesterday.
Brean analyst says, "We'd look to again become constructive on shares as the headwinds abate. While we've held a more favorable view of LXK's 'normalized' earnings potential that the street (and believe likely wil again once the dust settles), we also believe it's likely that 1) Street EPS comes down within the ballpark of our new estimates and 2) until both revenue and margins sustainably stabilize, LXK will likely garner just 7-8x multiple, likely capping upside until these forces work through."
For more ratings news on Lexmark International click here and for the rating history of Lexmark International click here.
Shares of Lexmark International closed at $32.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
DowngradesRelated Entities
Brean Murray Carret & Co., EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share